期刊文献+

CYP1B1基因多态性与子宫内膜癌易感性的关系 被引量:1

Association between gene polymorphism of CYP1B1 and susceptibility to endometrial cancer
下载PDF
导出
摘要 目的研究CYP1B1基因外显子3密码子432(C-G)多态性与子宫内膜癌易感性的关系。方法应用聚合酶链反应-限制性片断长度多态性分析(PCR-RFLP)技术检测76例子宫内膜癌患者和83例对照者的CYP1B1基因密码子432(C-G)位点多态性,并分析CYP1B1基因多态性与子宫内膜癌易感性的相关性。结果CYP1B1基因密码子432中等位基因C、G在子宫内膜癌组和对照组分布的差异有统计学意义(P〈0.05),其中等位基因G使子宫内膜癌发病风险增加2.24倍。CYP1B1基因密码子432C/G各基因型分布两组间差异有统计学意义(P〈0.05),纯合突变(G/G)基因型、杂合突变(C/G)基因型与野生(C/C)基因型相比,患子宫内膜癌的危险度分别提高了5.62倍和2.04倍。结论CYP1B1基因Leu432Val多态性与子宫内膜癌的发生有一定的关系,突变基因型增加子宫内膜癌的发病风险。 Objective To study the association between gene polymorphism of cytochrome P450 1B1 in exon 3 codon 432 (C - G ) and the susceptibility to endometrial cancer. Methods Polymerase chain reaction - restriction fragment length polymorphism was used to detect gene polymorphism in exon 3 codon 432( C - G) of CYP1B1 in 76 cases of endometrial cancer and 83 cases of normal control ,and analyze the relationship between gene polymorphism of cytochrome P450 1 B1 and the susceptibility to endometrial cancer. Results The frequency of allele C, G on codon 432 C/G of CYP1B1 between the endometrial cancer group and the control group showed a siginificant difference ( P 〈 0. 05 ), with an odds of 2.24. There was a siginificant difference in the frequency of genotype C/C, C/G, G/G between the two groups ( P 〈 0.05 ). Compared with wild - type C/C, the susceptibility of endometrial cancer with the genotypes of homozygotic mutation G/G and heterozygote mutation C/G was increased respectively by 5.62 and 2.04. Conclusion The gene polymorphism of cytochrome P450 1B1 in exon 3 codon 432 (C -G) is concern with the susceptibility to endometrial cancer. The mutation of CYP1B1 gene increases the risk of endometrial cancer.
出处 《中原医刊》 2007年第10期9-10,共2页 Central Plains Medical Journal
关键词 子宫内膜癌 CYP1B1基因 基因多态性 Endometrial cancer CYP1B1 gene Gene polymorphism
  • 相关文献

参考文献7

  • 1Lax SF,Kendall B,Tashiro H,et al. The frequency of p53,K2ras mutations and microsatellite instability differs in uterine endometrioid and serous carcinoma evidence of distinct molecular genetic pathways. Cancer,2000,88:814.
  • 2Richard SL, Bradley BJ, Alexander B. Estrogen metabolism and the diet - cancer connection : rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altem Med Rev ,2002,7 (2):112 -129.
  • 3Aklillu E, Oscarson M, Hidestrand M, et al. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Molpharmacol,2002,61 ( 3 ) : 586 - 594.
  • 4Rylander T,Wedren S,Granath F,et al. Cytochrome 17450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis,2003,24(9) :1533 - 1539.
  • 5Watanabe J, Shimada T, Gillam EM, et al. Association of CYP1B1 geneticpolymorphism with incidence to breast and lung cancer. Pharmacogenetics ,2000,10:25 - 33.
  • 6Sasaki M,Tanaka Y, Kaneuchi M, et al. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor α and estrogen receptor β expressions. Cancer Res ,2003,63:3913 - 3918.
  • 7Zheng W, Xie DW, Jin F, et al. Genetic polymorphism of cytochrome P450 1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prey,2000,9: 147 - 150.

同被引文献16

  • 1Service RF. New role for estrogen in cancer[J]. Science,1998, 279 (5357) : 1631 - 1633.
  • 2Goddard KA, Hopkins PJ, Hall JM, et al. Linkage disequilibrium and allele frequency distributions for 114 single - nucleotide polymorphisms in five population[J]. Am J Hum Genet, 2000, 66(1) : 216 -234.
  • 3Watanabe J, Shimada T, Gllam EM, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer J [ J ]. Pharna genetics,2000,10 ( 1 ) :25 - 33.
  • 4Stoilov I , Akarsu AN, Alozle I, et al. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p121 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P450 1 B1 [ J ]. J Hum Genet, 1998,62 : 573-584.
  • 5Aklillu E, Oscarson M, Hidestrand M, et al. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population [ J ]. Mol Pharmacol,2002, 61 (3) :586 - 594.
  • 6Aklillu E, Ovrebo S, Botnen IV, et al. Characterization of common CYPIB1 variants with different capacity for benzo[ a ] pyrene - 7,8 -Dihydrodiol epoxlde formation from benzo[ a] pyrene[ J]. Cancer Res, 2005, 65(12) :5105 -5111.
  • 7Masahiro S, Yuiehiro T, Masanori K, et al. CYP1B1 Gene polymerphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor and estrogen receptor β expressions [ J ]. Cancer Res, 2003, 63 (14) :3913 - 3918.
  • 8Watanabe J, Shimada T, Gillam EM, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer [ J ]. Pharmaeogenefies, 2000, 10:25 - 33.
  • 9Thyagarajan B, Brott M, Mink P, et al. CYPIB1 and CYP19 gene polymorph isms and breast cancer incidence: no association in the ARIC study[ J]. Cancer Lett, 2004, 207:183 - 189.
  • 10Bailey LR, Roodi N, Dupont WD, et al. Association of cytochrome P450 1B1 (CYPIB1) polymorphism with steroid receptor status in breast cancer[ J]. Cancer Res, 1998, 58:5038 - 5041.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部